Seeing Is Believing
Currently out of the existing stock ratings of Lisa Walter, 37 are a BUY (84.09%), 7 are a HOLD (15.91%).
Analyst Lisa Walter, currently employed at RBC, carries an average stock price target met ratio of 26.39% that have a potential upside of 21.13% achieved within 108 days.
Lisa Walter’s has documented 89 price targets and ratings displayed on 9 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on EYPT, Eyepoint Pharmaceuticals at 18-Aug-2026.
Analyst best performing recommendations are on EYPT (EYEPOINT PHARMACEUTICALS).
The best stock recommendation documented was for EYPT (EYEPOINT PHARMACEUTICALS) at 8/18/2026. The price target of $5 was fulfilled within 6 days with a profit of $0.47 (8.59%) receiving and performance score of 14.32.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 30-Apr-2024
$5
$0.64 (14.68%)
9 months 24 days ago
(17-Nov-2025)
0/5 (0%)
$0.73 (17.10%)
Buy Since 01-Nov-2023
$5.5
$1.14 (26.15%)
$12
10 months 12 days ago
(29-Oct-2025)
1/7 (14.29%)
$1.27 (30.02%)
292
Hold Since 16-Apr-2025
$4
$-0.36 (-8.26%)
$5
10 months 13 days ago
(28-Oct-2025)
1/2 (50%)
$-0.26 (-6.10%)
168
Buy Since 18-Jul-2024
1 years 28 days ago
(13-Aug-2025)
2/3 (66.67%)
$30.52 (321.94%)
1046
Hold Since 19-Mar-2024
$4
$-0.36 (-8.26%)
$5
1 years 3 months 26 days ago
(15-May-2025)
4/6 (66.67%)
$1.95 (95.12%)
205
Which stock is Lisa Walter most bullish on?
Which stock is Lisa Walter most reserved on?
What Year was the first public recommendation made by Lisa Walter?